Enhancement of the CXCL12/CXCR4 axis due to acquisition of gemcitabine resistance in pancreatic cancer: effect of CXCR4 antagonists
Crossref DOI link: https://doi.org/10.1186/s12885-016-2340-z
Published Online: 2016-05-12
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Morimoto, Mamoru
Matsuo, Yoichi
Koide, Shuji
Tsuboi, Ken
Shamoto, Tomoya
Sato, Takafumi
Saito, Kenta
Takahashi, Hiroki
Takeyama, Hiromitsu
Funding for this research was provided by:
JSPS KAKENHI Grant (15K10192)
